Skip to main content
. 2021 May 26;11:11001. doi: 10.1038/s41598-021-90215-5

Table 5.

Perioperative and short-term outcomes of patients treated with and without nCRT.

Before propensity score matching After propensity score matching
Open
(n = 147)
MIS
(n = 166)
p Open
(n = 118)
MIS
(n = 118)
p
MIS approach
Laparoscopic surgery 130 (78.3) 92 (78.0)
Robotic surgery 36 (21.7) 26 (22.0)
Operation time (minutes) 194 ± 67 237 ± 67  < 0.001 198 ± 71 238 ± 66  < 0.001
Stoma formation, n (%) 105 (71.4) 150 (90.4)  < 0.001 84 (71.2) 110 (93.2)  < 0.001
Transfusion, n (%) 9 (6.1) 2 (1.2) 0.018 9 (7.6) 2 (1.7) 0.031
Open conversion, n (%) 2 (1.2) 2 (1.7)
Readmission, n (%) 10 (6.8) 16 (9.6) 0.364 6 (5.1) 9 (7.6) 0.423
Postoperative morbidity 41 (27.9) 47 (28.3) 0.934 31 (26.3) 32 (27.1) 0.883
Surgical site infection 16 (10.9) 2 (1.2)  < 0.001 12 (10.2) 1 (0.8) 0.002
Postoperative ileus 17 (11.6) 11 (6.6) 0.127 11 (9.3) 6 (5.1) 0.208
Anastomosis site leakage 2 (1.4) 2 (1.2) 1.000 1 (0.8) 1 (0.8) 1.000
Rectovaginal fistula 2 (1.4) 2 (1.2) 1.000 1 (0.8) 0 (0.0) 0.500
Intra-abdominal abscess 2 (1.4) 2 (1.2) 1.000 0 (0.0) 0 (0.0) 1.000
Urinary retention 7 (4.8) 16 (9.6) 0.099 6 (5.1) 14 (11.9) 0.062
Postoperative mortality (< POD30) 0 (0.0) 0 (0.0) 1.000 0 (0.0) 0 (0.0) 1.000
Length of stay (days) 11.8 ± 4.9 9.6 ± 3.5  < 0.001 11.8 ± 4.9 9.5 ± 3.4  < 0.001
Time to diet (days) 2.1 ± 0.8 2.2 ± 0.6 0.433 2.5 ± 1.0 2.1 ± 0.5  < 0.001
Flatus passage (days) 2.5 ± 1.3 1.7 ± 0.9 0.070 2.9 ± 0.7 2.4 ± 1.1  < 0.001

nCRT neoadjuvant chemoradiotherapy, MIS minimally invasive surgery.